In this cohort, RARRES2 expression was found to be significantly decreased in BCBrM compared with primary breast tumors, and moreover, with primary brain tumors (GSE100534) (P = 0.0016, P = 0.0003, Fig. 1e). Here, RARRES2 is linked to breast neoplasm.